Selling Autologous Professional Standards -Myassignmenthelp.Com

Question: Discuss About The Selling Autologous Professional Standards? Answer: Introduction Stem cell research has brought forth the onset of a revolutionary innovation in the health care scenario and has helped to improve the healthcare industry remarkably. Stem cells or human embryonic cells have a clinical superpower for regenerative tissue repair and are now being concerned to be the future cure for a vast variety of different morbid diseases and disabilities. However, there is a great controversy associated with the research involving stem cells due to their origin being the human pre-implantation embryos[1]. This assignment will focus on the primary ethico-legal issues of stem cell research, pertinent laws and the conflicting position of the issue. It has to be understood that for all of the stem cell lines, embryonic tissues used are generally derived from the IVF by the means of therapeutic cloning, a that involves autologous transplantation of a somatic cell nucleus to an unfertilized egg. The key ethical issue with stem cell research is the absolute disregard to the value of life itself; the moral violation is facilitated by destruction of viable and potential human embryos which directly or indirectly is leading to an unethical expiration of the beginning phase of a possible human life. Hence the key moral or ethical issue is the violation of a key fundamental principle of humanity, respecting the value of human life[2]. There are various acts and legislations that relates to the use of stem cell research. Firstly, the Prohibition of Human Cloning for Reproduction and the Regulation of Human Embryo Research Amendment Act 2006 and Research Involving Human Embryos Regulations 2017 are the Nursing pertinent legislative resource providing the most of the protocol restriction on all kinds of biomedicine research involving stem cell research. Although the national stem cell centre is concerned with the existent stem cell research in Australia, however the compliance to the commonwealth and state territory laws of the research activity it overlooked by the NHMRC licensing committee[3]. It has to be mentioned that the stem cell research h has been nothing short of a major breakthrough in the field if regenerative biomedicine, although this research gives rise to a ethico-legal conflict than none other. The stem cell research attempts to improve the life of existing human lives at the seeming expense of ending that of the possible human lives. On one hand, one fundamental moral principle of preventing and alleviating the suffering of people is being exceptionally addressed by the stem cell. While on the other hand, another most fundamental moral principle of valuing human life above everything else is being violated heavily[4]. Hence the conflict on morality and the humanitarian consequence of ending numerous viable human lives is a great obstacle in the path of progressive biomedical research. The debate is consistent among various government and non-government stakeholders on whether the betterment of human lives by progressive research can justify the moral conflict of exploiting human embryos. References: Caulfield, Timothy, Christen Rachul, and Amy Zarzeczny. "The economics of policy issues in stem cell research: an international survey." Stem Cell Reviews and Reports 8, no. 4 (2012): 1037-1042. Commonwealth And State Legislation | National Health And Medical Research Council. 2018. Nhmrc.Gov.Au. https://www.nhmrc.gov.au/research/embryo-research-licensing/commonwealth-and-state- legislation. Li, Matthew D., Harold Atkins, and Tania Bubela. "The global landscape of stem cell clinical trials." Regenerative medicine 9, no. 1 (2014): 27-39. Munsie, M., Hyun, I. (2014). A question of ethics: selling autologous stem cell therapies flaunts professional standards. Stem cell research, accounting, 647-653.